The study of drug–reaction relationships using global optimization techniques

In this paper we develop an optimization approach for the study of adverse drug reaction (ADR) problems. This approach is based on drug–reaction relationships represented in the form of a vector of weights, which can be defined as a solution to some global optimization problem. Although it can be used for solving many ADR problems, we concentrate on two of them here: the accurate identification of drugs that are responsible for reactions that have occurred, and drug–drug interactions. Based on drug–reaction relationships, we formulate these problems as an optimization problem. The approach is applied to cardiovascularn-type reactions from the Australian Adverse Drug Reaction Advisory Committee (ADRAC) database. Software based on this approach has been developed and could have beneficial use in prescribing.

[1]  F. Landry,et al.  Recognizing, reporting, and reducing adverse drug reactions. , 2001, Southern medical journal.

[2]  M. Lindquist,et al.  Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study , 2001, BMJ : British Medical Journal.

[3]  William G Troutman,et al.  Comparison of voluntary adverse drug reaction reports and corresponding medical records. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  Yoram Singer,et al.  BoosTexter: A Boosting-based System for Text Categorization , 2000, Machine Learning.

[5]  Munir Pirmohamed,et al.  Fortnightly review: Adverse drug reactions , 1998 .

[6]  A. Bate,et al.  A Bayesian neural network method for adverse drug reaction signal generation , 1998, European Journal of Clinical Pharmacology.

[7]  Musa Mammadov,et al.  An Optimization Approach to Identify the Relationship between Features and Output of a Multi-label Classifier , 2007 .

[8]  William DuMouchel,et al.  Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System , 1999 .

[9]  R. O’Neill,et al.  Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database , 2002, Drug safety.

[10]  Emma Heeley,et al.  Prescription-event monitoring and reporting of adverse drug reactions , 2001, The Lancet.

[11]  Tamara G. Kolda,et al.  Optimization by Direct Search: New Perspectives on Some Classical and Modern Methods , 2003, SIAM Rev..

[12]  John Yearwood,et al.  A fuzzy derivative approach to classification of outcomes from the ADRAC database , 2004 .

[13]  Yiming Yang,et al.  A scalability analysis of classifiers in text categorization , 2003, SIGIR.

[14]  E. Puijenbroek,et al.  Application of Quantitative Signal Detection in the Dutch Spontaneous Reporting System for Adverse Drug Reactions , 2003, Drug safety.

[15]  Helen Prior,et al.  Safety pharmacology – a progressive approach , 2002, Fundamental & clinical pharmacology.

[16]  Jeffrey K Aronson,et al.  Adverse drug reactions: keeping up to date , 2002, Fundamental & clinical pharmacology.

[17]  Musa Mammadov,et al.  Dynamical Systems Described by Relational Elasticities with Applications , 2005 .

[18]  Yiming Yang,et al.  A re-examination of text categorization methods , 1999, SIGIR '99.